Subsequent Event (Details) - Subsequent Event - Wholly-owned subsidiary of ARIAD Pharmaceuticals, Inc - Stock purchase agreement $ in Millions	1 Months Ended
May. 31, 2016 USD ($)
Subsequent Event [Line Items]
Purchase price of common stock under Stock Purchase Agreement	$ 140
Development, Regulatory and Commercialization Milestones \| Maximum
Subsequent Event [Line Items]
Potential milestone payments to be made	$ 135

Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.

No definition available.

Name:	us-gaap_SubsequentEventLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration